Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution

Sponsor
Hôpital Armand Trousseau (Other)
Overall Status
Completed
CT.gov ID
NCT04651829
Collaborator
(none)
100
1
43
2.3

Study Details

Study Description

Brief Summary

Cow's milk protein allergy (CMPA) is often evoked in infants, in particular in front of delayed symptoms such as rectal bleeding, atopic dermatitis, excessive crying, reflux, failure to thrive... But in case of non IgE-mediated CMPA, the only way to diagnose this allergy is to proceed to an elimination-reintroduction test over a period of 2 to 4 weeks, to improve symptoms first, and then provoke them. Even if the diagnosis is confirmed, we speculate that non IgE-mediated CMPA has a faster resolution than other CMPA.

The first aim of this study is to estimate the prevalence of non IgE-mediated CMPA in a cohort of infants with delayed symptoms which could be relied to a CMPA. The second goal is evaluate the age of tolerance in non IgE-mediated CMPA with oral food challenge for milk ever 2 months after 4 months of age.

Condition or Disease Intervention/Treatment Phase
  • Other: oral food challenge 1
  • Other: oral food challenge 2

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Actual Study Start Date :
May 1, 2014
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
Dec 1, 2017

Outcome Measures

Primary Outcome Measures

  1. prevalence of CMPA in patients with suspicion of non IgE-mediated CMPA [2 to 8 weeks after inclusion]

    We proceed to an elimination-reintroduction test of the culprit food (CMP) in patients with delayed symptoms of non IgE-mediated CMPA (rectal bleeding, atopic dermatitis, reflux, excessive crying, failure to thrive...) after a period of two to eight weeks of exclusion of CMP. If symptoms disappear after CMP elimination, and reappear after CMP reintroduction, the diagnosis of CMPA is confirmed.

Secondary Outcome Measures

  1. age of tolerance of confirmed non IgE-mediated CMPA [after 4 months of age, and at least after 2 months of elimination diet, and then ever 2 months until tolerance]

    We proceed to an oral food challenge (OFC) for CMP every 2 months, after the age of 4 months, and after at least 2 months of elimination diet. If symptoms occur after OFC, the patient is still allergic. If no symptom occur after OFC, the patient is considered as tolerant for CMP, and that determine age of tolerance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 4 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • infants under 4 months age with delayed symptoms evoking CMPA
Exclusion Criteria:
  • exclusively breastfed infants

  • no improvement of symptoms despite amino acid formula

  • patients with symptoms of food protein induced enterocolitis

  • patients who do not have diagnostic oral food challenge within 3 months after the start of elimination diet

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pediatric nutrition and gastroenterology department, Trousseau Hospital, APHP Paris France 75012

Sponsors and Collaborators

  • Hôpital Armand Trousseau

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anaïs Lemoine, Dr, MD, Hôpital Armand Trousseau
ClinicalTrials.gov Identifier:
NCT04651829
Other Study ID Numbers:
  • CMPA
First Posted:
Dec 3, 2020
Last Update Posted:
Dec 3, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 3, 2020